Sulfisoxazole Elicits Robust Antitumour Immune Response Along with Immune Checkpoint Therapy by Inhibiting Exosomal PD‐L1
Sign Up to like & getrecommendations! Published in 2021 at "Advanced Science"
DOI: 10.1002/advs.202103245
Abstract: Despite their potent antitumor activity, clinical application of immune checkpoint inhibitors has been significantly limited by their poor response rates ( read more here.
Keywords: sulfisoxazole elicits; response; elicits robust; immune checkpoint ... See more keywords